The authors thank Dr Oriol Mitjà (Lihir Medical Center, Papua New Guinea), Dr Jacob Kool (World Health Organization, Vanuatu), Ms Fasihah Taleo (Ministry of Health, Vanuatu), Abdul Aziz Abdulai (Ghana Health Service) and Dr Matthew Coldiron (Médecins Sans Frontières, France) for sharing their experiences from the pilot sites; Dr Michael Marks (London School of Hygiene and Tropical Medicine), other participants of the Third WHO Consultation on Yaws Eradication and three anonymous reviewers for their comments; and Matthew Madin-Warburton for his review and synthesis of the evidence on the cost of mass drug administration. The content is solely the responsibility of the authors and does not represent the official views of WHO.